A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC) Article

Web of Science: 000459277302312
Industry Collaboration International Collaboration

Cited authors

  • Hidalgo, M.; Epelbaum, R.; Wolpin, B. M.; Stemmer, S. M.; Geva, R.; Golan, T.; Borazanci, E.; Borad, M.; Pedersen, K. S.; Park, J. O.; Ramirez, R.; Peled, A.; Lustig, T. M.; Kashtan, O. Bohana; Rosenfeld, O.; Sorani, E.; Schlienger, K.; Haras, A. Vainstein; Von Hoff, D. D.

Publication date

  • 2018

Published in

International Standard Serial Number (ISSN)

  • 0923-7534


  • 29